Magnetic resonance imaging of the brain in patients with pseudoexfoliation syndrome and glaucoma

Ophthalmologica

Volumn 220, Issue 2, 2006, Pages 125-130

  Yüksel, Nurşen ^a,b   Anik, Yonca ^a   Altintaş, Özgül ^a   Onur, Inci ^a   Çaǧlar, Yusuf ^a   Demirci, Ali ^a  

^a KOCAELI UNIVERSITY   (Turkey)

^b NONE   (Turkey)

Author keywords

Brain magnetic resonance imaging; Glaucoma; Pseudoexfoliation; White matter hyperintensities

Indexed keywords

ADULT; AGED; ARTICLE; BRAIN ISCHEMIA; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLAUCOMA; HUMAN; IMAGING SYSTEM; MALE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OPHTHALMOLOGY; PREVALENCE; PSEUDOEXFOLIATION; RATING SCALE; STATISTICAL SIGNIFICANCE; SYNDROME; VALIDATION PROCESS; WHITE MATTER;

AGED; BRAIN; CASE-CONTROL STUDIES; EXFOLIATION SYNDROME; FEMALE; GLAUCOMA; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; SEVERITY OF ILLNESS INDEX;

EID: 33344476641     PISSN: 00303755     EISSN: None     Source Type: Journal    
DOI: 10.1159/000090578     Document Type: Article

References (38)

1. Ritch R, Schlötzer-Schrehardt U: Exfoliation syndrome. Surv Ophthalmol 2001;45:265-315.
2. Asano N, Schlötzer-Schrehardt U, Naumann GOH: A histopathologic study of iris changes in pseudoexfoliation syndrome. Ophthalmology 1995;102:1279-1290.
3. Helbig H, Schlötzer-Schrehardt U, Noske W, Kellner U, Foerster MH, Naumann GOH: Anterior-chamber hypoxia and iris vasculopathy in pseudoexfoliation syndrome. Ger J Ophthalmol 1994;3:148-153.
4. Khalil AK, Kuboto T, Tawara A, Inomata H: Early changes in iris blood vessels in exfoliation syndrome. Curr Eye Res 1998;17:1124-1134.
5. Cursiefen C, Hammer T, Küchle M, Naumann GOH, Schlötzer- Schrehardt U: Pseudoexfoliation syndrome in eyes with ischemic central retinal vein occlusion: a histopathologic and electron microscopic study. Acta Ophthalmol Scand 2001;79:476-478.
6. Naumann GOH, Schlötzer-Schrehardt U, Küchle M: Pseudoexfoliation syndrome for the comprehensive ophthalmologist: intraocular and systemic manifestations. Ophthalmology 1998;105:951-968.
7. Schlötzer-Schrehardt U, Koca MH, Naumann GOH, Volkholz H: Pseudoexfoliation syndrome: ocular manifestation of a systemic disorder? Arch Ophthalmol 1992;110:1752-1756.
8. Schlötzer-Schrehardt U, Küchle M, Naumann GOH: Electron-microscopic identification of pseudoexfoliation material in extrabulbar tissue. Arch Ophthalmol 1991;109:565-570.
9. Streeten BW, Dark AJ, Wallace RN, Li ZY, Hoepner JA: Pseudoexfoliative fibrillopathy in the skin of patients with ocular pseudoexfoliation. Am J Ophthalmol 1990;110:490-499.
10. Streeten BW, Li Z-Y, Wallace RN, Eagle RC, Keshgegian AA: Pseudoexfoliative fibrillopathy in visceral organs of a patient with pseudoexfoliation syndrome. Arch Ophthalmol 1992;110:1757-1762.
11. Li ZY, Streeten BW, Wallace RN: Association of elastin with pseudoexfoliative material: an immunoelectron microscopic study. Curr Eye Res 1988;7:1163-1172.
12. Mitchell P, Wang JJ, Smith W: Association of pseudoexfoliation syndrome with increased vascular risk. Am J Ophthalmol 1997;124: 685-687.
13. Schumacher S, Schlötzer-Schrehardt U, Martus P, Lang W, Nauman GOH: Pseudoexfoliation syndrome and aneurysms of the abdominal aorta. Lancet 2001;357:359-360.
14. Repo LP, Terasvirta ME, Koivito KJ: Generalized transluminance of the iris and the frequency of the pseudoexfoliation syndrome in the eyes of transient ischemic attack patients. Ophthalmology 1993;100:352-355.
15. Yüksel N, Karabas L, Arslan A, Demirci A, Çaǧlar Y: Ocular hemodynamics in pseudoexfoliation syndrome and pseudoexfoliation glaucoma. Ophthalmology 2001;108:1043-1049.
16. Yüksel N, Anik Y, Kiliç A, Karabaş VL, Çaǧlar Y, Demirci A: Cerebrovascular blood flow velocities in pseudoexfoliation. Graefes Arch Clin Exp Ophthalmol, in press.
17. Linnér E, Popovic V, Gottfries C-G, Sjogren M, Wallin A: The exfoliation syndrome in cognitive impairment of cerebrovascular or Alzheimer's type. Acta Ophthalmol Scand 2001;79:283-285.
18. Ringvold A, Blika S, Sandvik L: Pseudoexfoliation and mortality. Acta Ophthalmol Scand 1997;75:255-256.
19. Shrüm KR, Hattenhauer MG, Hodge D: Cardiovascular and cerebrovascular mortality associated with ocular pseudoexfoliation. Am J Ophthalmol 2000;129:83-86.
20. Schmidt R, Hayn M, Fazekas F, Kapeller P, Esterbauer H: Magnetic resonance imaging white matter hyperintensities in clinically normal elderly individuals: correlations with plasma concentrations of naturally occurring antioxidants. Stroke 1996;27:2043-2047.
21. Fazekas F, Kleinert R, Offenbacher H, Schmidt R, Kleinert G, Payer F, Radner H, Lechner H: Pathologic correlates of incidental white matter signal hyperintensities. Neurology 1993;43:1683-1689.
22. Pantoni L: Pathophysiology of age-related cerebral white matter changes. Cerebrovasc Dis 2002;13(suppl 2):7-10.
23. Hogervorst E, Ribeiro HM, Molyneux A, Budge M, Smith AD: Plasma homocysteine levels, cerebrovascular risk factors, and cerebral white matter changes (leukoaraiosis) in patients with Alzheimer disease. Arch Neurol 2002;59:787-793.
24. Kudo T, Imaizumi K, Tanimukai H, Katayama T, Sato N, Nakamura Y, Tanaka T, Kashiwagi Y, Jinno Y, Tohyama M, Takeda M: Are cerebrovascular factors involved in Alzheimer's disease? Neurobiol Aging 2000;21:215-224.
25. Onk K, Farinelli A, Billson F, Houang M, Stern M: Comparative study of brain magnetic resonance imaging findings in patients with low-tension glaucoma and control subjects. Ophthalmology 1995;102:1632-1638.
26. Stroman GA, Stewart WC, Golnic KC, Cure JK, Olinger RE: Magnetic resonance imaging in patients with low tension glaucoma. Arch Ophthalmol 1995;113:168-172.
27. Claus JJ, Breteler MMB, Hasan D, Krenning EP, Bots ML, Grobbee DE, Van Swieten JC, Harskamp FV, Hofman A: Regional cerebral blood flow and cerebrovascular risk factors in the elderly population. Neurobiol Aging 1998;19:57-64.
28. Pantoni L, Garcia JH, Gutierrez JA: Cerebral white matter is highly vulnerable to ischemia. Stroke 1996;27:1641-1647.
29. Puustjärvi T, Blomster H, Kontkanen M, Punnonen K, Teräsvirta M: Plasma and aqueous humour levels of homocysteine in exfoliation syndrome. Graefes Arch Clin Exp Ophthalmol 2004;242:749-754.
30. Tyagi SC: Homocysteine redox receptor and regulation of extracellular matrix components in vascular cells. Am J Physiol 1998;274:396-405.
31. Eagle RC, Font RL, Fine BS: The basement membrane exfoliation syndrome. Arch Ophthalmol 1979;97:510-515.
32. Graham IM, Daly LE, Refsum HM, Robinson K, Brattstrom LE, Ueland PM, et al: Plasma homocysteine: a risk factor for vascular disease. The European Concerted Action Project. JAMA 1997;277:1775-1781.
33. Leibovitch I, Kurtz S, Shemesh G, Goldstein M, Sela B, Lazar M, Loewenstein A: Hyperhomocystinemia in pseudoexfoliation glaucoma. J Glaucoma 2003;12:36-38.
34. Vermeer SE, van Dijk EJ, Koudstaal Pjreteler MM: Homocysteine levels, cerebrovascular risk factors, and cerebral white matter lesions. The Rotterdam Scan Study. Ann Neurol 2002;51:285-289.
35. Vessani RM, Ritch R, Leibmann JM, Jofe M: Plasma homocysteine is elevated in patients with exfoliation syndrome. Am J Ophthalmol 2003;1:41-46.
36. Bescond A, Augier T, Chareyre C, et al: Influence of homocysteine on matrix metalloproteinase 2: activation and activity. Biochem Biophys Res Commun 1999;263:498-503.
37. Moore P, EL-Sherbeny A, Roon P, et al: Apoptotic cell death in the mouse retinal ganglion cell layer is induced in vivo by the excitatory amino acid homocysteine. Exp Eye Res 2001; 73:45-57.
38. de Leeuw F-E, de Groot JC, Achten E, Oudkerk M, Ramos LMP, Heijboer R, Hofman A, Jolles J, Gijn J, Breteler MMB: Prevalence of cerebral white matter lesions in elderly people: a population-based magnetic resonance imaging study. The Rotterdam Scan Study J Neurol Neurosurg Psychiatry 2001;70:9-14.